CuraTeQ Biologics, the wholly owned step-down subsidiary of Aurobindo Pharma Ltd, on 2 July announced that it has obtained marketing authorisation from the European Commission...
Shares of Biocon, Zydus Lifesciences, and Aurobindo Pharma moved higher by up to 2% after the companies announced regulatory milestones achieved in the US and...
Share of Aurobindo Pharma Ltd surged 4% on 23 April after the companyβs wholly-owned subsidiary announced securing final approval from the US Food and Drug...
Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, which is the...
Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...
Shares of Aurobindo Pharma Ltd slumped 2% on 28 January despite the company declaring that the Telangana active pharmaceutical ingredient (API) factory owned by one...
Shares of Aurobindo Pharma Ltd were trading in the green and 1.8% higher on 23 December after the company’s step-down subsidiary, CuraTeQ Biologics s.r.o., announced...
Shares of Aurobindo Pharma Ltd. dropped 1% from a day’s high of Rs 1,559.90 on 18th September after the company announced that its step-down subsidiary,...
Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...